Ad is loading...
ELEV
Price
$0.53
Change
-$0.05 (-8.62%)
Updated
Nov 15 closing price
108 days until earnings call
ONPPF
Price
$0.27
Change
-$0.00 (-0.00%)
Updated
May 3 closing price
Ad is loading...

ELEV vs ONPPF

Header iconELEV vs ONPPF Comparison
Open Charts ELEV vs ONPPFBanner chart's image
Elevation Oncology
Price$0.53
Change-$0.05 (-8.62%)
Volume$777.74K
CapitalizationN/A
ONCOPEPTIDES AB
Price$0.27
Change-$0.00 (-0.00%)
Volume$200
CapitalizationN/A
ELEV vs ONPPF Comparison Chart
Loading...
ELEV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ELEV vs. ONPPF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELEV is a StrongSell and ONPPF is a Buy.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ELEV: $0.53 vs. ONPPF: $0.26)
Brand notoriety: ELEV and ONPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELEV: 103% vs. ONPPF: 100%
Market capitalization -- ELEV: $31.42M vs. ONPPF: $29.02M
ELEV [@Biotechnology] is valued at $31.42M. ONPPF’s [@Biotechnology] market capitalization is $29.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELEV’s FA Score shows that 1 FA rating(s) are green whileONPPF’s FA Score has 0 green FA rating(s).

  • ELEV’s FA Score: 1 green, 4 red.
  • ONPPF’s FA Score: 0 green, 5 red.
According to our system of comparison, ELEV is a better buy in the long-term than ONPPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELEV’s TA Score shows that 4 TA indicator(s) are bullish.

  • ELEV’s TA Score: 4 bullish, 5 bearish.

Price Growth

ELEV (@Biotechnology) experienced а -18.22% price change this week, while ONPPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ELEV is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELEV($31.4M) has a higher market cap than ONPPF($29M). ELEV YTD gains are higher at: -1.024 vs. ONPPF (-55.833). ELEV has higher annual earnings (EBITDA): -40.8M vs. ONPPF (-246.4M). ONPPF has more cash in the bank: 383M vs. ELEV (111M). ELEV has less debt than ONPPF: ELEV (30.9M) vs ONPPF (115M). ONPPF has higher revenues than ELEV: ONPPF (21.4M) vs ELEV (0).
ELEVONPPFELEV / ONPPF
Capitalization31.4M29M108%
EBITDA-40.8M-246.4M17%
Gain YTD-1.024-55.8332%
P/E RatioN/AN/A-
Revenue021.4M-
Total Cash111M383M29%
Total Debt30.9M115M27%
TECHNICAL ANALYSIS
Technical Analysis
ELEV
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Ad is loading...
ELEV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGRO11.370.62
+5.77%
Adecoagro SA
BIDU84.580.53
+0.62%
Baidu
CRVL344.74-1.93
-0.56%
CorVel Corp
PLUR5.38-0.07
-1.28%
Pluri
LXFR14.34-0.31
-2.12%
Luxfer Holdings PLC

ELEV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELEV has been loosely correlated with NKTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ELEV jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELEV
1D Price
Change %
ELEV100%
-8.41%
NKTX - ELEV
37%
Loosely correlated
-6.30%
BOLT - ELEV
31%
Poorly correlated
-9.14%
TBPH - ELEV
30%
Poorly correlated
-0.52%
IMNM - ELEV
29%
Poorly correlated
-11.09%
CLDX - ELEV
27%
Poorly correlated
-8.51%
More

ONPPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONPPF has been loosely correlated with IPHYF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ONPPF jumps, then IPHYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONPPF
1D Price
Change %
ONPPF100%
N/A
IPHYF - ONPPF
41%
Loosely correlated
N/A
AEON - ONPPF
39%
Loosely correlated
+0.87%
OTLK - ONPPF
20%
Poorly correlated
-1.81%
CRDF - ONPPF
20%
Poorly correlated
-9.15%
ELEV - ONPPF
2%
Poorly correlated
-8.41%
More